137 related articles for article (PubMed ID: 20030620)
41. Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via cyclic GMP.
Gower WR; Vesely BA; Alli AA; Vesely DL
Int J Gastrointest Cancer; 2005; 36(2):77-87. PubMed ID: 16648657
[TBL] [Abstract][Full Text] [Related]
42. Natriuretic peptides as regulatory mediators of secretory activity in the digestive system.
Sabbatini ME
Regul Pept; 2009 Apr; 154(1-3):5-15. PubMed ID: 19233231
[TBL] [Abstract][Full Text] [Related]
43. Atrial natriuretic peptide and long-acting natriuretic peptide inhibit ras in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Lenz A; Skelton WP; Wang H; Vesely DL
Anticancer Res; 2009 Jun; 29(6):1889-93. PubMed ID: 19528444
[TBL] [Abstract][Full Text] [Related]
44. Atrial natriuretic hormone, vessel dilator, long acting natriuretic hormone, and kaliuretic hormone decrease circulating prolactin concentrations.
Vesely DL; San Miguel GI; Hassan I; Schocken DD
Horm Metab Res; 2002 May; 34(5):245-9. PubMed ID: 12063637
[TBL] [Abstract][Full Text] [Related]
45. Cardiac hormones are potent inhibitors of secreted frizzled-related protein-3 in human cancer cells.
Skelton WP; Skelton M; Vesely DL
Exp Ther Med; 2013 Feb; 5(2):475-478. PubMed ID: 23408665
[TBL] [Abstract][Full Text] [Related]
46. Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Skelton WP; Lenz A; Wang H; Vesely DL
Anticancer Res; 2009 Apr; 29(4):971-5. PubMed ID: 19414334
[TBL] [Abstract][Full Text] [Related]
47. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
[TBL] [Abstract][Full Text] [Related]
48. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells.
Nazario B; Hu RM; Pedram A; Prins B; Levin ER
J Clin Invest; 1995 Mar; 95(3):1151-7. PubMed ID: 7883964
[TBL] [Abstract][Full Text] [Related]
49. Vessel dilator: most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of human squamous lung cancer cells.
Vesely BA; Fitz SR; Gower WR; Vesely DL
Cancer Lett; 2006 Feb; 233(2):226-31. PubMed ID: 15893414
[TBL] [Abstract][Full Text] [Related]
50. Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.
Yamamoto K; Ikeda U; Shimada K
J Mol Cell Cardiol; 1997 Sep; 29(9):2375-82. PubMed ID: 9299361
[TBL] [Abstract][Full Text] [Related]
51. Natriuretic peptides in relation to the cardiac innervation and conduction system.
Hansson M
Microsc Res Tech; 2002 Sep; 58(5):378-86. PubMed ID: 12226807
[TBL] [Abstract][Full Text] [Related]
52. Four cardiac hormones cause cell death of melanoma cells and inhibit their DNA synthesis.
Vesely BA; Eichelbaum EJ; Alli AA; Sun Y; Gower WR; Vesely DL
Am J Med Sci; 2007 Nov; 334(5):342-9. PubMed ID: 18004088
[TBL] [Abstract][Full Text] [Related]
53. Primary malignant tumors of the heart: four cardiovascular hormones decrease the number and DNA synthesis of human angiosarcoma cells.
Vesely BA; Alli A; Song S; Sanchez-Ramos J; Fitz SR; Gower WR; Vesely DL
Cardiology; 2006; 105(4):226-33. PubMed ID: 16534199
[TBL] [Abstract][Full Text] [Related]
54. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep.
Charles CJ; Espiner EA; Richards AM; Nicholls MG; Yandle TG
Am J Physiol; 1996 Jun; 270(6 Pt 2):R1324-31. PubMed ID: 8764300
[TBL] [Abstract][Full Text] [Related]
55. [Atrial natriuretic hormones and metabolic syndrome: recent advances].
Benomar K; Espiard S; Loyer C; Jannin A; Vantyghem MC
Presse Med; 2018 Feb; 47(2):116-124. PubMed ID: 29496376
[TBL] [Abstract][Full Text] [Related]
56. Twice-weekly intravenous treatment of pancreatic cancer with atrial natriuretic peptide and vessel dilator.
Lenz A; Sun Y; Eichelbaum EJ; Skelton WP; Pi G; Vesely DL
In Vivo; 2010; 24(2):125-9. PubMed ID: 20363982
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
58. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
Crook RB; Chang AT
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
[TBL] [Abstract][Full Text] [Related]
59. [Natriuretic peptide family].
Hirata Y
Nihon Rinsho; 1993 May; 51(5):1156-64. PubMed ID: 8392634
[TBL] [Abstract][Full Text] [Related]
60. Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells.
Suzuki E; Hirata Y; Kohmoto O; Sugimoto T; Hayakawa H; Matsuoka H; Sugimoto T; Kojima M; Kangawa K; Minamino N
Circ Res; 1992 Nov; 71(5):1039-48. PubMed ID: 1394868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
